Home/Products /paclitaxel-ip-6mg-polyoxyl-35-castor-oil-ip-527mg-dehydrtes-alcohol-ip-49-7-v-v-30mg-injection

Packlin 30 Injection: Paclitaxel 30 mg - The Low-Wastage Chemo Vial

Name: Packlin 30: Paclitaxel Injection 30 mg
Brand: Packlin 30 Injection
Rating: 4.8 (150 reviews)

Microtubule Stabilization: The Anti-Cancer Mechanism of Paclitaxel

Primary Indication: First-line and Adjuvant Therapy for Breast and Ovarian Cancer

Dosage Accuracy: Advantages of the 30 mg Vial for Weight-Based Protocols

Important: Specialized Administration and Pre-medication Protocol

Secure Your Monopoly: Packlin 30 PCD Pharma Franchise in Cost-Effective Injectable Oncology

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Paclitaxel 30 mg injection vial for chemotherapy

Close-up of small chemotherapy vial showing accurate dosing

Hospital staff preparing low-dose Paclitaxel infusion

Oncology PCD Pharma franchise marketing visual for injectable Paclitaxel

Packlin 30 injection (Paclitaxel) Administration and Wastage Prevention Guide PDF

Packlin 30 Injection

Composition : Paclitaxel IP 6mg + Polyoxyl 35 Castor oil IP 527mg + Dehydrtes Alcohol IP 49.7% v/v

Dosage Form : Injection

Packaging Type : Vial

Packaging : 30gm

Price : ₹0/-

Please Contact For Best Price

Packlin 30 Injection is a critical intravenous chemotherapy solution containing Paclitaxel , an essential drug in the Taxane class. This smallest presentation is highly valued in clinical settings for achieving precise, low-dose administration protocols (e.g., weekly regimens, pediatric oncology) and for significantly minimizing the costly drug wastage often associated with larger vials.

Mechanism and Impact:Paclitaxel is a cytotoxic agent that acts by stabilizing microtubules, preventing their breakdown and essential restructuring required for cell division. This forces the rapidly dividing cancer cells (Breast, Ovarian, Lung, etc.) into mitotic arrest, leading to programmed cell death.

Key Therapeutic Uses:

Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
Cost-Efficiency: The $30 mg$ vial is a preferred option for doses that would otherwise require discarding significant amounts of drug from larger vials.

We offer an exclusive PCD Pharma Franchise opportunity for Packlin 30 Injection, enabling partners to meet the strong institutional demand for flexible, low-wastage oncology injectables.

About the Product

Key Therapeutic Uses:

Breast Cancer: Used in adjuvant, neoadjuvant, and metastatic settings.
Ovarian Cancer: Standard treatment for advanced ovarian carcinoma.
Non-Small Cell Lung Cancer (NSCLC): Used in combination regimens.
Cost-Efficiency: The $30 mg$ vial is a preferred option for doses that would otherwise require discarding significant amounts of drug from larger vials.

We offer an exclusive PCD Pharma Franchise opportunity for Packlin 30 Injection, enabling partners to meet the strong institutional demand for flexible, low-wastage oncology injectables.

Hair loss (alopecia) Nausea, vomiting, diarrhea Low blood counts (anemia, leukopenia) Peripheral neuropathy (tingling or numbness) Joint/muscle pain

Metastatic breast cancer Advanced ovarian carcinoma Non-small cell lung cancer (NSCLC) AIDS-related Kaposi’s sarcoma Often used as first-line or second-line therapy, either alone or in combination with other chemotherapeutic agents like cisplatin.

Administered intravenously by trained professionals in a clinical setting. Premedication with corticosteroids, antihistamines, and H2 antagonists is essential to minimize hypersensitivity reactions. Requires close monitoring of blood counts, liver function, and cardiac status.

Store below 25°C, protected from light. Do not freeze. Shake well before use. Keep out of reach of children.